Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer
Article in Cancers (March 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in Cancers (March 2024)
Article in Biomedicines (July 2023)
Article in Endocrines (June 2023)